◀ Back to DNM1

DNM1 — UGCG

Text-mined interactions from Literome

Bijl et al., Hepatology 2009 (Liver Neoplasms) : We have shown that the iminosugar N- ( 5'-adamantane-1'-yl-methoxy ) -pentyl-1-deoxynojirimycin ( AMP-DNM ), an inhibitor of the enzyme glucosylceramide synthase , is a potent enhancer of insulin signaling in rodent models for insulin resistance and type 2 diabetes
Bijl et al., Hepatology 2009 (Disease Models, Animal...) : We have shown that the iminosugar N- ( 5'-adamantane-1'-yl-methoxy ) -pentyl-1-deoxynojirimycin ( AMP-DNM ), an inhibitor of the enzyme glucosylceramide synthase , is a potent enhancer of insulin signaling in rodent models for insulin resistance and type 2 diabetes